FindTrial
Sign In

Patients Response in Laparoscopic Gynaecological Surgeries Following Instillation Of Levo-Bupivacaine Intraperitoneally

Patients Response in Laparoscopic Gynaecological Surgeries Following Instillation Of Levo-Bupivacaine Intraperitoneally â?? A Randomised Prospective Control Study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/020152
Enrollment
90
Registered
2019-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D279- Benign neoplasm of unspecified ovary Health Condition 2: N809- Endometriosis, unspecified Health Condition 3: D251- Intramural leiomyoma of uterus Health Condition 4: N925- Other specified irregular menstruation

Interventions

Intervention1: Levo-Bupivacaine: 20 ML of 0.5% Levo-Bupivacaine Diluted in 40 ML normal saline Instilled Intra-Peritoneally Control Intervention1: Control: 60 ML of normal saline Instilled Intra-Perit

Sponsors

DR ASIF MUSTAFA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The study will include ASA-I &II women presenting to Max Smart super specialty Hospital Saket for elective laparoscopic Gynecological surgery meeting the inclusion criteria as described below: 1) ASA I &II patients. 2) Age 18-70yrs. 3) elective surgery

Exclusion criteria

Exclusion criteria: The study will include ASA-I &II women presenting to Max Smart super specialty Hospital Saket for elective laparoscopic Gynecological surgery with exclusion criteria as described below: 1) ASA III and above patients 2) Use of opioids within 24hrs prior to study 3) Drugs & alcohol abuse 3) History of allergy to any drug used in study. 4) Patients having chronic pain syndrome 5) Treatment with steroids prior to surgery 6) Patient with diagnostic laparoscopy without surgical procedure. 7) Patients who do not understand VAS pain scale. 8) Patients not willing to be included in the study- not giving consent.

Design outcomes

Primary

MeasureTime frame
To evaluate whether instillation of levo-bupivacaine intraperitoneal decreases post operative pain after laparoscopic gynecological surgeries, using VAS pain Scale.Timepoint: 24 HOURS POST SURGERY—

Secondary

MeasureTime frame
1.To assess requirement of rescue analgesia in post operative periods.Timepoint: Hourly till 24 Hours Post Surgery;2.To assess whether the incidence of PONV (post operative nausea and vomiting) reduces in the study group. Timepoint: 24 HOURS POST SURGERY—

Countries

India

Contacts

Public ContactDr Manju Mani

Max Smart Super Speciality Hospital

mukulanjali@gmail.com011-71212121

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026